University of Alabama at BirminghamBirmingham, Alabama, United States
Disclosure information not submitted.
2C-04 - Randomization to Holding versus Continuing (JAKi, IL17) and Autoimmune Patient Responses to COVID-19 Boosters: Results from the Covid-19 VaccinE Response in Rheumatology Patients (COVER) Study
Sunday, August 24, 20254:15 PM - 4:30 PM ET
5F-04 - Treatment Sequencing and Line of Therapy for Biologics and JAK inhibitors in Rheumatoid Arthritis Patients: Implications for Design and Uptake of New Drugs and Diagnostics
Tuesday, August 26, 20259:15 AM - 9:30 AM ET
